[APVO] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[APVO] Aptevo Therapeutics Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 48.06%
YoY- 44.88%
Quarter Report
APVO's Result
APVO's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 0 3,096 1,463 9,011 5,824 6,172 9,405 -
PBT -7,809 -7,077 -6,948 -11,174 -12,601 -10,784 -71,747 -30.89%
Tax -140 -80 -157 -999 -39 -13,768 -6 69.00%
NP -7,669 -6,997 -6,791 -6,924 -12,562 37,867 -71,741 -31.09%
Tax Rate - - - - - - - -
Total Cost 7,669 10,093 8,254 15,935 18,386 -31,695 81,146 -32.49%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 0.00 -226.00 -464.18 -76.84 -215.69 613.53 -762.80 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -66.29 -63.08 -92.43 -94.43 -341.30 85.95 -2,185.29 -44.13%
EPS Diluted -66.29 -62.93 -92.43 -94.43 -341.30 85.95 -2,183.83 -44.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.